CARDINAL HEALTH — Alprazolam Importer Profile
Pharmaceutical Importer · #9 buyer for Alprazolam · $423.3K import value · 11 shipments · UNITED STATES · DGFT Verified
CARDINAL HEALTH is the #9 importer of Alprazolam from India with $423.3K in import value and 11 verified shipments. CARDINAL HEALTH holds a 2.6% market share in Alprazolam imports based in UNITED STATES. The company sources from 1 verified supplier across 10 formulations shipped to 1 country. Overall, CARDINAL HEALTH imports 5 pharmaceutical products worth $10.0M across 4 therapeutic categories.
CARDINAL HEALTH — Alprazolam Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Alprazolam to CARDINAL HEALTH?
Verified from 11 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $423.3K | 11 | 100.0% |
CARDINAL HEALTH sources Alprazolam from 1 verified Indian supplier based on 11 customs records. The primary supplier is CENTAUR PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does CARDINAL HEALTH Compare to Nearest Alprazolam Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | AUROBINDO PHARMA USA., INC, | UNITED STATES | $521.3K | 48 | $10.9K |
| 8 | AUROBINDO PHARMA USA INC | UNITED STATES | $427.2K | 25 | $17.1K |
| 9 | CARDINAL HEALTH ★ | UNITED STATES | $423.3K | 11 | $38.5K |
| 10 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $303.9K | 8 | $38.0K |
| 11 | SUN PHARMA EAST AFRICA LIMITED | KENYA | $295.4K | 16 | $18.5K |
CARDINAL HEALTH ranks #9 among 82 Alprazolam importers from India. Average shipment value of $38.5K compared to the market average of $175.6K. The closest competitors by value are AUROBINDO PHARMA USA., INC, and AUROBINDO PHARMA USA INC.
Where Does CARDINAL HEALTH Import Alprazolam To?
Destination countries from 11 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $423.3K | 11 | 100.0% |
CARDINAL HEALTH imports Alprazolam to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $423.3K.
What Alprazolam Formulations Does CARDINAL HEALTH Import?
| Formulation | Value | Shipments |
|---|---|---|
| ALPRAZOLAM TABLETS USP 2 MG -500'S EACH | $69.3K | 2 |
| ALPRAZOLAM TABLETS USP 1 MG-100'S EACH T | $48.8K | 1 |
| ALPRAZOLAM TABLETS USP 1 MG -100'S EACH | $48.8K | 1 |
| ALPRAZOLAM TABLETS USP 1 MG - 1000'S EAC | $47.2K | 1 |
| ALPRAZOLAM TABLETS USP 0.5 MG-100'S EACH | $46.1K | 1 |
| ALPRAZOLAM TABLETS USP 0.5 MG-100S EACH | $46.0K | 1 |
| ALPRAZOLAM TABLETS USP 0.25 MG-100'S EAC | $44.0K | 1 |
| ALPRAZOLAM TABLETS USP 1 MG -500'S EACH | $27.4K | 1 |
| ALPRAZOLAM TABLETS USP 2 MG-500 S EACH T | $23.0K | 1 |
| ALPRAZOLAM TABLETS USP 1 MG -1000'S EACH | $22.7K | 1 |
CARDINAL HEALTH imports 10 distinct Alprazolam formulations from India. The top formulation is ALPRAZOLAM TABLETS USP 2 MG -500'S EACH with 2 shipments worth $69.3K.
Regulatory Requirements: Importing Alprazolam into United States
What CARDINAL HEALTH and other importers must comply with to import Alprazolam from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Alprazolam
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Alprazolam from India and How Much Does CARDINAL HEALTH Import?
India exported $14.4M worth of Alprazolam through 654 shipments from 39 suppliers to 24 countries, serving 82 buyers globally. CARDINAL HEALTH imports $423.3K of this total, accounting for 2.6% of India's Alprazolam exports with 11 shipments from UNITED STATES. This is verified from 11 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for CARDINAL HEALTH's Alprazolam Imports?
CARDINAL HEALTH's average Alprazolam order value is $38.5K per consignment, based on 11 shipments totaling $423.3K. CARDINAL HEALTH is based in UNITED STATES and ranks #9 among all Alprazolam importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Alprazolam to CARDINAL HEALTH?
CARDINAL HEALTH sources Alprazolam from 1 verified Indian supplier: CENTAUR PHARMACEUTICALS PRIVATE LIMITED ($423.3K, 100.0%). This is based on 11 customs records.
How Does CARDINAL HEALTH Compare to Other Alprazolam Importers?
CARDINAL HEALTH ranks #9 among 82 Alprazolam importers from India with a 2.6% market share. The top 3 importers are ACTAVIS LABORATORIES FL, INC. ($3.9M), ACTAVIS LABORATORIES FL INC ($2.5M), SANDOZ INC. C/O EXEL, INC. ($2.0M). CARDINAL HEALTH processed 11 shipments from UNITED STATES.
About CARDINAL HEALTH
CARDINAL HEALTH imports 5 products worth $10.0M. Beyond Alprazolam, top products include Clindamycin, Diclofenac, Tetracycline, Exemestane. View the complete CARDINAL HEALTH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Alprazolam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Alprazolam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CARDINAL HEALTH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CARDINAL HEALTH's capped import value divided by total capped export value for Alprazolam across all Indian exporters.
- 5.Verified Records: This page is backed by 11 individual customs records matching CARDINAL HEALTH importing Alprazolam, covering 10 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 24+ countries, 82+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Alprazolam Import Data for CARDINAL HEALTH
Access order-level details, pricing data, supplier connections, and competitive analysis for CARDINAL HEALTH's Alprazolam imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CARDINAL HEALTH
Full Company Profile →
5 products · $10.0M total trade · 4 categories
CARDINAL HEALTH × Alprazolam
Verified from customs records
Company Overview
Top Products by CARDINAL HEALTH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CARDINAL HEALTH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Alprazolam. For current order-level data, contact TransData Nexus.